Engaging patients, family members and caregivers in end-of-life and palliative care (EOLPC) research: Addressing the bioethical challenges
让患者、家庭成员和护理人员参与临终关怀和姑息治疗 (EOLPC) 研究:应对生物伦理挑战
基本信息
- 批准号:9927885
- 负责人:
- 金额:$ 15.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-28 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministrative SupplementAmericanAttentionBeliefBioethical IssuesBioethicsCaregiversChronic DiseaseCommunitiesDecision MakingDiseaseElderlyEnsureEnvironmentEthical IssuesEthicsEvaluationFaceFamilyFamily CaregiverFamily memberFrail ElderlyFundingGeographyGoalsGrief reactionHealthHealth Services AccessibilityImpairmentIndividualInstitute of Medicine (U.S.)Interdisciplinary StudyInterviewJusticeMethodsOutcomePalliative CareParticipantPatient CarePatient PreferencesPatient-Focused OutcomesPatientsPersonal SatisfactionPersonsPhasePoliciesPopulationQuality of CareQuality of lifeResearchResearch InstituteResearch PersonnelResearch Project GrantsResourcesScienceShapesSiteStructureSupport GroupsTimeUnited States National Institutes of HealthVulnerable Populationsadvanced dementiabasedecision-making capacitydissemination researchend of lifeevidence baseexperienceimplementation researchimprovedinnovationinsightinvestigator trainingmembernovelpatient engagementpatient orientedpatient populationpopulation healthpreferencepsychologicracial and ethnicrecruitresearch data disseminationsocialsocioeconomics
项目摘要
PROJECT ABSTRACT
For the millions of Americans who experience the possible physical, psychological, and social effects of severe
and chronic illness, palliative care can be essential to supporting an optimal quality of life. Estimates suggest
that two-thirds of all people in the US could benefit from palliative care at some point, and this estimate does
not include the family members and caregivers who may also benefit. The delivery of high-quality, patient-
centered palliative care depends upon end-of-life and palliative care (EOLPC) Research. Realizing the full
benefits of palliative care research requires the engagement of patients, families, and caregivers in every
phase of research. Effective engagement can make research better by increasing the relevance of research
questions to patients, enhancing recruitment, and improving dissemination & implementation of research
results. However, engagement can raise ethical challenges - such as ensuring engagement participants are
truly representative of the broader patient population and that engagement does not present undue burdens –
that have only recently been explored, but not in EOLPC Research. Because EOLPC Research is a unique
setting, it can present unique ethical challenges to effective engagement. Patients may be vulnerable due to
their state of illness (such as in the frail elderly) or due to absent or intermittent decision-making capacity.
Family caregivers may struggle to know and represent patients' priorities or have difficulty engaging due to
ongoing grief. Any potential ethical challenges may be particularly relevant for individuals who are doubly
vulnerable because of existing racial, ethnic, socioeconomic, and geographic disparities in access to EOLPC.
Explicitly eliciting their preferences about research is critical for shaping research that meets their needs. The
goals of this project are to advance the science of bioethics and engagement in research and to provide ethics
guidance to support researchers in engaging palliative care patients, caregivers, and others in EOLPC
Research. We will achieve this goal by (1) using semi-structured interviews to obtain insights into the real-
world ethical challenges facing investigators as well as patients, family members, and caregivers in EOLPC
research engagement; (2) defining outcomes of importance to the different stakeholders; and (3) creating
practical ethics guidance for identifying and managing ethical issues in engaging patients in EOLPC research.
The project will be conducted within the Palliative Care Research Cooperative Group (PCRC) (U2C
NR014637), a robust interdisciplinary research community comprised of more than 500 members at more than
180 sites. This supplement will build on the existing resources of the PCRC to enhance the patient-centered
palliative care research and address gaps in the evidence base related to patient engagement in EOLPC
Research.
项目摘要
对于数百万遭受严重疾病可能造成的身体、心理和社会影响的美国人来说
和慢性病,姑息治疗对于支持最佳生活质量至关重要。估计建议
美国三分之二的人可能会在某个时候受益于姑息治疗,这一估计确实
不包括也可能受益的家庭成员和护理人员。提供高质量、耐心的服务
以临终关怀和姑息治疗 (EOLPC) 研究为中心的姑息治疗。实现全面
姑息治疗研究的好处需要患者、家属和护理人员的参与
研究阶段。有效的参与可以通过提高研究的相关性来使研究变得更好
向患者提问、加强招募、改善研究的传播和实施
结果。然而,参与可能会带来道德挑战——例如确保参与参与者
真正代表更广泛的患者群体,并且参与不会带来不当的负担 –
最近才被探索过,但 EOLPC 研究中还没有。因为 EOLPC 研究是一个独特的
在这种情况下,它可能会对有效参与提出独特的道德挑战。患者可能因以下原因而变得脆弱
他们的疾病状况(例如体弱的老年人)或由于缺乏或间歇性的决策能力。
家庭护理人员可能很难了解并代表患者的优先事项,或者由于以下原因而难以参与:
持续的悲伤。任何潜在的道德挑战可能与双重身份的个人特别相关
由于在获得 EOLPC 方面存在的种族、民族、社会经济和地理差异,该群体处于弱势地位。
明确地激发他们对研究的偏好对于塑造满足他们需求的研究至关重要。这
该项目的目标是推进生物伦理学和研究参与,并提供伦理学
支持研究人员让姑息治疗患者、护理人员和其他人参与 EOLPC 的指南
研究。我们将通过以下方式实现这一目标:(1)使用半结构化访谈来深入了解真实情况
EOLPC 中的研究人员以及患者、家属和护理人员面临的世界伦理挑战
研究参与; (2) 定义对不同利益相关者重要的结果; (3) 创建
用于识别和管理患者参与 EOLPC 研究过程中的伦理问题的实用伦理指南。
该项目将在姑息治疗研究合作组织 (PCRC) (U2C
NR014637),一个强大的跨学科研究社区,由超过 500 名成员组成
180 个站点。该补充文件将建立在 PCRC 现有资源的基础上,以加强以患者为中心的服务
姑息治疗研究并解决与患者参与 EOLPC 相关的证据基础差距
研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEAN S KUTNER其他文献
JEAN S KUTNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEAN S KUTNER', 18)}}的其他基金
Diversifying and Strengthening Dementia Palliative Care Clinical Trials
多样化和加强痴呆症姑息治疗临床试验
- 批准号:
10409239 - 财政年份:2022
- 资助金额:
$ 15.53万 - 项目类别:
Diversifying and Strengthening Dementia Palliative Care Clinical Trials
多样化和加强痴呆症姑息治疗临床试验
- 批准号:
10626045 - 财政年份:2022
- 资助金额:
$ 15.53万 - 项目类别:
Multidisciplinary Research Training in Palliative Care
姑息治疗的多学科研究培训
- 批准号:
8666995 - 财政年份:2014
- 资助金额:
$ 15.53万 - 项目类别:
Multidisciplinary Research Training in Palliative Care
姑息治疗的多学科研究培训
- 批准号:
9922826 - 财政年份:2014
- 资助金额:
$ 15.53万 - 项目类别:
Palliative Care Research Cooperative Group (PCRC): Refinement and Expansion
姑息治疗研究合作小组 (PCRC):细化和扩展
- 批准号:
10331658 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Refinement and Expansion of the Palliative Care Research Cooperative Group (PCRC)
姑息治疗研究合作小组 (PCRC) 的完善和扩大
- 批准号:
8926710 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Palliative Care Research Cooperative Group (PCRC): Refinement and Expansion
姑息治疗研究合作小组 (PCRC):细化和扩展
- 批准号:
10207778 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Palliative Care Research Cooperative Group (PCRC): Project Coordinating Center
姑息治疗研究合作小组 (PCRC):项目协调中心
- 批准号:
10207779 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Refinement and Expansion of the Palliative Care Research Cooperative Group (PCRC)
姑息治疗研究合作小组 (PCRC) 的完善和扩大
- 批准号:
9108177 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
Palliative Care Research Cooperative Group (PCRC): Project Coordinating Center
姑息治疗研究合作小组 (PCRC):项目协调中心
- 批准号:
10438796 - 财政年份:2013
- 资助金额:
$ 15.53万 - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 15.53万 - 项目类别:














{{item.name}}会员




